Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
-
- Qing Zhong
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
-
- Chi-Fen Chen
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
-
- Shang Li
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
-
- Yumay Chen
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
-
- Chuan-Cheng Wang
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
-
- Jun Xiao
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
-
- Phang-Lang Chen
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
-
- Z. Dave Sharp
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
-
- Wen-Hwa Lee
- Department of Molecular Medicine, Institute of Biotechnology, University of Texas Health Science Center at San Antonio, 15355 Lambda Drive, San Antonio, TX 78245, USA.
抄録
<jats:p> <jats:italic>BRCA1</jats:italic> encodes a tumor suppressor that is mutated in familial breast and ovarian cancers. Here, it is shown that BRCA1 interacts in vitro and in vivo with hRad50, which forms a complex with hMre11 and p95/nibrin. Upon irradiation, BRCA1 was detected in discrete foci in the nucleus, which colocalize with hRad50. Formation of irradiation-induced foci positive for BRCA1, hRad50, hMre11, or p95 was dramatically reduced in HCC/1937 breast cancer cells carrying a homozygous mutation in <jats:italic>BRCA1</jats:italic> but was restored by transfection of wild-type <jats:italic>BRCA1</jats:italic> . Ectopic expression of wild-type, but not mutated, <jats:italic>BRCA1</jats:italic> in these cells rendered them less sensitive to the DNA damage agent, methyl methanesulfonate. These data suggest that BRCA1 is important for the cellular responses to DNA damage that are mediated by the hRad50-hMre11-p95 complex. </jats:p>
収録刊行物
-
- Science
-
Science 285 (5428), 747-750, 1999-07-30
American Association for the Advancement of Science (AAAS)
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1361418519154748544
-
- NII論文ID
- 30020365322
-
- ISSN
- 10959203
- 00368075
-
- データソース種別
-
- Crossref
- CiNii Articles